iBio, Inc. (IBIO)
0.7823
+0.01
(+1.77%)
USD |
NASDAQ |
Nov 02, 16:00
0.7853
0.00 (0.00%)
After-Hours: 16:58
iBio Market Cap : 43.57M for Nov. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 30, 2026 | 42.82M |
| October 29, 2026 | 45.32M |
| October 28, 2026 | 44.79M |
| October 27, 2026 | 42.72M |
| October 26, 2026 | 39.38M |
| October 23, 2026 | 39.98M |
| October 22, 2026 | 43.67M |
| October 21, 2026 | 46.79M |
| October 20, 2026 | 45.73M |
| October 19, 2026 | 42.34M |
| October 16, 2026 | 42.68M |
| October 15, 2026 | 43.60M |
| October 14, 2026 | 43.49M |
| October 13, 2026 | 43.55M |
| October 12, 2026 | 50.31M |
| October 09, 2026 | 48.51M |
| October 08, 2026 | 51.24M |
| October 07, 2026 | 56.26M |
| October 06, 2026 | 58.48M |
| October 05, 2026 | 62.38M |
| October 02, 2026 | 62.66M |
| October 01, 2026 | 61.83M |
| September 30, 2026 | 65.72M |
| September 29, 2026 | 65.17M |
| September 28, 2026 | 65.17M |
| Date | Value |
|---|---|
| September 25, 2026 | 66.28M |
| September 24, 2026 | 66.84M |
| September 23, 2026 | 69.34M |
| September 22, 2026 | 74.08M |
| September 21, 2026 | 70.18M |
| September 18, 2026 | 71.29M |
| September 17, 2026 | 69.62M |
| September 16, 2026 | 65.72M |
| September 15, 2026 | 66.28M |
| September 14, 2026 | 66.84M |
| September 11, 2026 | 67.12M |
| September 10, 2026 | 68.23M |
| September 09, 2026 | 70.18M |
| September 08, 2026 | 72.41M |
| September 04, 2026 | 72.97M |
| September 03, 2026 | 72.41M |
| September 02, 2026 | 72.97M |
| September 01, 2026 | 70.18M |
| August 31, 2026 | 70.74M |
| August 28, 2026 | 75.75M |
| August 27, 2026 | 77.98M |
| August 26, 2026 | 79.65M |
| August 25, 2026 | 81.88M |
| August 24, 2026 | 49.05M |
| August 21, 2026 | 49.40M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.523B |
| Alnylam Pharmaceuticals, Inc. | 21.14B |
| Anika Therapeutics, Inc. | 259.03M |
| Savara, Inc. | 970.51M |
| Vericel Corp. | 2.074B |
Market Cap Related Metrics
| PS Ratio | 640.34 |
| Price to Book Value | 0.5083 |
| Price | 0.7823 |
| Earnings Yield | -57.98% |